Life sciences professionals will need to keep up with market demand for biologics and biosimilars.
Theresa Vuskovich
Advertisement
Articles by Theresa Vuskovich
Advertisement
Latest Updated Articles
Addressing the Knowledge Gap in Biologics & Biosimilars: Is a Board Certified Biologics and Biosimilars Program the Answer?Published: November 4th 2022 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Moderna Investing $140 Million in Massachusetts Manufacturing Facility
2
Winners & Losers: What the First FDA Commissioner’s National Priority Vouchers Tell Us About Early Movers vs. Late Movers
3
Pharmaceutical Executive Daily: FDA's Approval of Epkinly
4
GSK Announces Research Collaborations with LTZ and Fleming Initiative
5
